Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Tracing differences between male and female breast cancer: both diseases own a different biology.

Kornegoor R, van Diest PJ, Buerger H, Korsching E.

Histopathology. 2015 May 1. doi: 10.1111/his.12727. [Epub ahead of print]

PMID:
25941088
2.

Chromosome 17 copy number changes in male breast cancer.

Lacle MM, Moelans CB, Kornegoor R, van der Pol C, Witkamp AJ, van der Wall E, Rueschoff J, Buerger H, van Diest PJ.

Cell Oncol (Dordr). 2015 Apr 24. [Epub ahead of print]

PMID:
25906114
3.

Combination of microvascular medial femoral condyle and iliac crest flap for hemi-midface reconstruction.

Brandtner C, Hachleitner J, Buerger H, Gaggl A.

Int J Oral Maxillofac Surg. 2015 Jun;44(6):692-6. doi: 10.1016/j.ijom.2015.03.006. Epub 2015 Mar 30.

PMID:
25835757
4.

Comparative study of the osseous healing process following three different techniques of bone augmentation in the mandible: an experimental study.

Benlidayi ME, Gaggl A, Buerger H, Kahraman OE, Sencar L, Brandtner C, Kurkcu M, Polat S, Borumandi F.

Int J Oral Maxillofac Surg. 2014 Nov;43(11):1404-10. doi: 10.1016/j.ijom.2014.07.004. Epub 2014 Aug 1.

PMID:
25091894
5.

Reconstruction with vascularized medial femoral condyle flaps in hindfoot and ankle defects: a report of two cases.

Mattiassich G, Marcovici LL, Dorninger L, Kerschhagl M, Buerger H, Kroepfl A, Larcher L.

Microsurgery. 2014 Oct;34(7):576-81. doi: 10.1002/micr.22286. Epub 2014 Jun 18.

PMID:
24942331
6.

Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification.

Lacle MM, Kornegoor R, Moelans CB, Maes-Verschuur AH, van der Pol C, Witkamp AJ, van der Wall E, Rueschoff J, Buerger H, van Diest PJ.

Mod Pathol. 2013 Nov;26(11):1461-7. doi: 10.1038/modpathol.2013.94. Epub 2013 Jun 7.

7.

Immunophenotyping of male breast cancer.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ.

Histopathology. 2012 Dec;61(6):1145-55. doi: 10.1111/j.1365-2559.2012.04330.x. Epub 2012 Sep 7.

PMID:
22958056
8.

Is there 'progression through grade' in ductal invasive breast cancer?

Schymik B, Buerger H, Krämer A, Voss U, van der Groep P, Meinerz W, van Diest PJ, Korsching E.

Breast Cancer Res Treat. 2012 Oct;135(3):693-703. doi: 10.1007/s10549-012-2195-1. Epub 2012 Aug 12.

PMID:
22886478
9.

Fibrotic focus and hypoxia in male breast cancer.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ.

Mod Pathol. 2012 Oct;25(10):1397-404. doi: 10.1038/modpathol.2012.101. Epub 2012 Jun 8.

10.

Origin and differentiation of breast nipple syringoma.

Boecker W, Junkers T, Reusch M, Buerger H, Korsching E, Metze D, Decker T, Loening T, Lange A, Samoilova V, Buchwalow I.

Sci Rep. 2012;2:226. doi: 10.1038/srep00226. Epub 2012 Jan 17. No abstract available.

11.

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.

Ercan C, van Diest PJ, van der Ende B, Hinrichs J, Bult P, Buerger H, van der Wall E, Derksen PW.

Cell Oncol (Dordr). 2012 Apr;35(2):111-8. doi: 10.1007/s13402-012-0071-y. Epub 2012 Feb 22.

12.

The 3-layered ductal epithelium in gynecomastia.

Kornegoor R, Verschuur-Maes AH, Buerger H, van Diest PJ.

Am J Surg Pathol. 2012 May;36(5):762-8. doi: 10.1097/PAS.0b013e31824324e6.

PMID:
22314184
13.

Molecular subtyping of male breast cancer by immunohistochemistry.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, van der Groep P, Hinrichs B, van Diest PJ.

Mod Pathol. 2012 Mar;25(3):398-404. doi: 10.1038/modpathol.2011.174. Epub 2011 Nov 4.

14.

Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.

Liedtke C, Packeisen J, Hess KR, Vogt U, Kiesel L, Kersting C, Korsching E, Brandt B, Buerger H.

Eur J Cancer. 2012 Sep;48(13):2066-74. doi: 10.1016/j.ejca.2011.08.006. Epub 2011 Sep 13.

PMID:
21920731
15.

Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.

Hungermann D, Schmidt H, Natrajan R, Tidow N, Poos K, Reis-Filho JS, Brandt B, Buerger H, Korsching E.

J Pathol. 2011 Aug;224(4):517-28. doi: 10.1002/path.2938. Epub 2011 Jun 27.

PMID:
21706489
16.

A short-term in vivo model for giant cell tumor of bone.

Balke M, Neumann A, Szuhai K, Agelopoulos K, August C, Gosheger G, Hogendoorn PC, Athanasou N, Buerger H, Hagedorn M.

BMC Cancer. 2011 Jun 13;11:241. doi: 10.1186/1471-2407-11-241.

17.

Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane.

Balke M, Neumann A, Kersting C, Agelopoulos K, Gebert C, Gosheger G, Buerger H, Hagedorn M.

BMC Res Notes. 2010 Mar 4;3:58. doi: 10.1186/1756-0500-3-58.

18.

Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.

Agelopoulos K, Greve B, Schmidt H, Pospisil H, Kurtz S, Bartkowiak K, Andreas A, Wieczorek M, Korsching E, Buerger H, Brandt B.

BMC Cancer. 2010 Mar 3;10:78. doi: 10.1186/1471-2407-10-78.

19.

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.

Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C.

Genes Chromosomes Cancer. 2010 Jan;49(1):40-51. doi: 10.1002/gcc.20717.

PMID:
19787792
20.

TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.

Helms MW, Kemming D, Contag CH, Pospisil H, Bartkowiak K, Wang A, Chang SY, Buerger H, Brandt BH.

Cancer Res. 2009 Jun 15;69(12):5049-56. doi: 10.1158/0008-5472.CAN-08-4154. Epub 2009 Jun 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk